On Wednesday, in a significant development drugmaker Pfizer Inc said, all of its patented medicines including COVID-19 treatment Paxlovid and big-selling breast cancer drug Ibrance will be made available at not-for-profit prices to 45 of the world’s poorest countries. The bouquet… Read More ›
Britain has opposed Saudi Arabia’s inclusion in the list because of it probably bad for business, especially for the City of London. In a significant development, the European Commission has added a host of countries including Saudi Arabia, Nigeria, Panama,… Read More ›
This marks AB InBev’s final disinvestment following its acquisition of SABMiller. Subject to regulatory approvals, this deal is set to close by the end of 2017. In a development that underscores AB In-Bev’s push to consolidate its acquisition of SABMiller,… Read More ›
manageria.biz 